Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5+ colorectal cancer

Haoran Feng(Shanghai Jiao Tong University), Ren Zhao(Shanghai Jiao Tong University)
Cell Death and Disease
October 24, 2020
Cited by 75


Related Papers